Publicaciones en las que colabora con María Dolores Pérez Vázquez (20)

2024

  1. Characterization of an outbreak caused by Elizabethkingia miricola using Fourier-transform infrared (FTIR) spectroscopy

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 4, pp. 797-803

  2. Clinical, microbiological, and molecular characterization of pediatric invasive infections by Streptococcus pyogenes in Spain in a context of global outbreak

    mSphere, Vol. 9, Núm. 3

2023

  1. An increase in erythromycin resistance in methicillin-susceptible Staphylococcus aureus from blood correlates with the use of macrolide/lincosamide/streptogramin antibiotics. EARS-Net Spain (2004–2020)

    Frontiers in Microbiology, Vol. 14

  2. Carbapenemase-Producing Klebsiella pneumoniae in COVID-19 Intensive Care Patients: Identification of IncL-VIM-1 Plasmid in Previously Non-Predominant Sequence Types

    Antibiotics, Vol. 12, Núm. 1

  3. Corrigendum: Phenotypic and molecular characterization of IMP-producing Enterobacterales in Spain: predominance of IMP-8 in Klebsiella pneumoniae and IMP-22 in Enterobacter roggenkampii (Frontiers in Microbiology, (2022), 13, (1000787), 10.3389/fmicb.2022.1000787)

    Frontiers in Microbiology

2022

  1. Phenotypic and molecular characterization of IMP-producing Enterobacterales in Spain: Predominance of IMP-8 in Klebsiella pneumoniae and IMP-22 in Enterobacter roggenkampii

    Frontiers in Microbiology, Vol. 13

2020

  1. Carbapenemase-producing Pseudomonas aeruginosa in Spain: interregional dissemination of the high-risk clones ST175 and ST244 carrying blaVIM-2, blaVIM-1, blaIMP-8, blaVIM-20 and blaKPC-2

    International Journal of Antimicrobial Agents, Vol. 56, Núm. 1

  2. Interregional spread in Spain of linezolid-resistant Enterococcus spp. isolates carrying the optrA and poxtA genes

    International Journal of Antimicrobial Agents, Vol. 55, Núm. 6

  3. Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 182-187

2017

  1. Carbapenem-resistant Citrobacter spp. isolated in Spain from 2013 to 2015 produced a variety of carbapenemases including VIM-1, OXA-48, KPC-2, NDM-1 and VIM-2

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 12, pp. 3283-3287

  2. The carbapenemase-producing Klebsiella pneumoniae population is distinct and more clonal than the carbapenem-susceptible population

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 4

2016

  1. Carbapenemase-producing Escherichia coli is becoming more prevalent in Spain mainly because of the polyclonal dissemination of OXA-48

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 8, pp. 2131-2138

2013

  1. Novel mechanisms of resistance to β-lactam antibiotics in Haemophilus parainfluenzae: β-lactamase-negative ampicillin resistance and inhibitor-resistant TEM β-lactamases

    Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 5, pp. 1054-1059

2010

  1. AmpC β-lactamases in Escherichia coli: Emergence of CMY-2-producing virulent phylogroup D isolates belonging mainly to STs 57, 115, 354, 393, and 420, and phylogroup B2 isolates belonging to the international clone O25b-ST131

    Diagnostic Microbiology and Infectious Disease, Vol. 67, Núm. 3, pp. 270-276

2009

  1. Methicillin-resistant Staphylococcus aureus in Spain: Molecular epidemiology and utility of different typing methods

    Journal of Clinical Microbiology, Vol. 47, Núm. 6, pp. 1620-1627

2008

  1. Antibiotic resistance in Haemophilus influenzae decreased, except for β-lactamase-negative amoxicillin-resistant isolates, in parallel with community antibiotic consumption in spain from 1997 to 2007

    Antimicrobial Agents and Chemotherapy, Vol. 52, Núm. 8, pp. 2760-2766

2007

  1. Ampicillin-resistant non-β-lactamase-producing Haemophilus influenzae in Spain: Recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime

    Antimicrobial Agents and Chemotherapy, Vol. 51, Núm. 7, pp. 2564-2573

2006

  1. Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions

    Journal of Clinical Microbiology, Vol. 44, Núm. 7, pp. 2359-2366

2003

  1. Antibiotic resistance and clinical significance of Haemophilus influenzae type f

    Journal of Antimicrobial Chemotherapy, Vol. 52, Núm. 6, pp. 961-966

  2. Infections due to Haemophilus influenzae serotype e: Microbiological, clinical, and epidemiological features

    Clinical Infectious Diseases, Vol. 37, Núm. 6, pp. 841-845